Ristocetin

von Willebrand factor ; Homo sapiens







438 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 16024332 Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates. 2005 2
152 16320153 Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. 2005 Dec 3
153 14754609 A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. 2004 Jan 1
154 14757772 Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis. 2004 Apr 16 4
155 14962219 Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P). 2004 Jan 2
156 15311161 A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). 2004 Sep 2
157 15333037 Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas. 2004 Sep 1
158 15333040 A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations. 2004 Sep 3
159 15467896 Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. 2004 Oct 4
160 15493507 Role of the Pyk2-MAP kinase-cPLA2 signaling pathway in shear-dependent platelet aggregation. 2004 Sep 1
161 12588351 A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease. 2003 Feb 2
162 12791664 Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation. 2003 Sep 15 1
163 12817908 A new flow cytometric method for measurement of von Willebrand factor activity. 2003 3
164 12871453 Platelet functional defects in women with unexplained menorrhagia. 2003 Mar 2
165 12871509 von Willebrand factor (VWF)-dependent human platelet activation: porcine VWF utilizes different transmembrane signaling pathways than does thrombin to activate platelets, but both require protein phosphatase function. 2003 Feb 1
166 12871537 An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. 2003 Jan 1
167 12923581 Acquired von Willebrand syndrome in a myeloproliferative disorder. Case 6. 2003 Aug 1
168 12932308 Mild forms of von Willebrand disease: diagnosis and management. 2003 Sep 2
169 14521604 Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. 2003 Oct 2
170 14750934 Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy. 2003 Nov 1
171 11756169 Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 2002 Jan 1 1
172 11772401 Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway. 2002 Jan 15 1
173 11943773 Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond. 2002 Jun 14 2
174 11948601 Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibalpha using optical tweezers. 2002 1
175 11992238 Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor. 2002 Apr 4
176 11992239 A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. 2002 Apr 1
177 11994985 Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. 2002 May 3
178 12008954 Release from intracellular stores is responsible for calcium signaling with von Willebrand factor in human platelets. 2002 Apr 1
179 12010796 Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. 2002 Jun 1 1
180 12038791 A novel polymorphism, 70Leu/Phe, disrupts a consensus Leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ibalpha. 2002 May 1
181 12152679 Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor. 2002 Jul 1
182 12176890 The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF. 2002 Sep 1 1
183 12214161 Low-dosage intravenous immunoglobulin in the management of a patient with acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance. 2002 Jan-Feb 1
184 12223999 Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). 2002 Aug 2
185 12410584 Effect of ABO blood group on the collagen-binding assay for von Willebrand factor. 2002 Nov 1
186 11150026 Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 2001 Jan 5
187 11159522 The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor. 2001 Feb 15 1
188 11181425 Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. 2001 Feb 1
189 11190800 Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. 2001 Jan 1
190 11240613 Use of ristocetin cofactor activity in the management of von Willebrand disease. 2001 Jan 2
191 11278380 Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal. 2001 May 18 1
192 11279169 Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding. 2001 May 18 2
193 11292197 Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 2001 Apr 2
194 11341505 Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. 2001 Apr 2
195 11468163 Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha. 2001 Aug 1 1
196 11535515 Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations. 2001 Sep 15 1
197 11547362 Recombinant von Willebrand factor: preclinical development. 2001 Aug 1
198 11686107 Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. 2001 Jun 3
199 11981108 Anti-vWf antibodies induce GPIbalpha and FcgammaRII mediated platelet aggregation only at low shear forces. 2001 Dec 1
200 17903829 Plasma von Willebrand factor activities in vascular Parkinsonism: comparison with Parkinson's disease. 2001 Sep-Oct 1